447 related articles for article (PubMed ID: 28161579)
61. Efficacy of a high quality O
Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
[TBL] [Abstract][Full Text] [Related]
62. Immunoprotective mechanisms in swine within the "grey zone" in antibody response after immunization with foot-and-mouth disease vaccine.
Zhang L; Feng X; Jin Y; Ma J; Cai H; Zhang X
Virus Res; 2016 Jul; 220():39-46. PubMed ID: 27067203
[TBL] [Abstract][Full Text] [Related]
63. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
[TBL] [Abstract][Full Text] [Related]
64. CpG-enriched plasmid enhances the efficacy of the traditional foot-and-mouth disease killed vaccine.
Guo X; Jia H; Zhang Q; Yuan W; Zhu G; Xin T; Zhu H; Sánchez-Vizcaíno JM
Microbiol Immunol; 2012 May; 56(5):332-7. PubMed ID: 22335800
[TBL] [Abstract][Full Text] [Related]
65. Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid.
Lee JH; Kang IJ; Kim AR; Noh YS; Chung HC; Park BK
J Vet Sci; 2016 Jun; 17(2):253-6. PubMed ID: 26645341
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
67. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
68. Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.
Lee HB; Piao DC; Lee JY; Choi JY; Bok JD; Cho CS; Kang SK; Choi YJ
Microb Cell Fact; 2017 Feb; 16(1):33. PubMed ID: 28228147
[TBL] [Abstract][Full Text] [Related]
69. Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate.
Lee HS; Park SY; Kim AY; Lee SO; Kim JS; Kim H; Youn HJ; Ko YJ
J Vet Med Sci; 2020 Aug; 82(8):1155-1159. PubMed ID: 32581148
[TBL] [Abstract][Full Text] [Related]
70. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
Horsington J; Nfon C; Gonzales JL; Singanallur N; Bittner H; Vosloo W
Vaccine; 2018 Oct; 36(41):6095-6102. PubMed ID: 30195485
[TBL] [Abstract][Full Text] [Related]
71. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
[TBL] [Abstract][Full Text] [Related]
72. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
73. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
74. Antigenic properties of a novel vaccine strain for type Asia1 foot-and-mouth disease in pigs.
Shin SH; Jo H; Ko MK; Choi JH; You SH; Jo HE; Lee MJ; Kim SM; Kim B; Park JH
Vet Microbiol; 2020 Sep; 248():108802. PubMed ID: 32827925
[TBL] [Abstract][Full Text] [Related]
75. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
[TBL] [Abstract][Full Text] [Related]
76. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
[TBL] [Abstract][Full Text] [Related]
77. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
78. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
[TBL] [Abstract][Full Text] [Related]
79. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
[TBL] [Abstract][Full Text] [Related]
80. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
